Volitionrx Ltd SEC filings VNRX
Volitionrx Ltd has 1,004 filings in SEC EDGAR's recent list, going back to Aug 27, 2013. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3/A | Form s-3/a | Sep 9, 2026 | — |
| S-3/A | Form s-3/a | Sep 8, 2026 | — |
| S-3 | Shelf registration | Aug 28, 2026 | — |
| S-8 | Employee stock plan registration | Aug 21, 2026 | — |
| S-3 | Shelf registration | Jul 10, 2026 | — |
| 424B5 | Prospectus supplement | Jun 9, 2026 | — |
| 424B5 | Prospectus supplement | Jun 5, 2026 | — |
| S-3 | Shelf registration | Feb 9, 2026 | — |
| 424B5 | Prospectus supplement | Oct 14, 2025 | — |
| 424B5 | Prospectus supplement | Oct 9, 2025 | — |
| 424B5 | Prospectus supplement | Aug 14, 2025 | — |
| 424B5 | Prospectus supplement | Aug 4, 2025 | — |
| S-3 | Shelf registration | Jul 3, 2025 | — |
| 424B5 | Prospectus supplement | Apr 22, 2025 | — |
| S-3/A | Form s-3/a | Apr 11, 2025 | — |
| S-1 | Registration statement | Apr 4, 2025 | — |
| 424B5 | Prospectus supplement | Mar 26, 2025 | — |
| 424B5 | Prospectus supplement | Dec 9, 2024 | — |
| S-3 | Shelf registration | Nov 8, 2024 | — |
| 424B5 | Prospectus supplement | Aug 12, 2024 | — |
| S-8 | Employee stock plan registration | Jul 24, 2024 | — |
| 424B3 | Prospectus | Jun 25, 2024 | — |
| S-3 | Shelf registration | Jun 14, 2024 | — |
| S-8 | Employee stock plan registration | Jul 14, 2023 | — |
| 424B5 | Prospectus supplement | Jun 2, 2023 | — |
| 424B5 | Prospectus supplement | May 31, 2023 | — |
| 424B5 | Prospectus supplement | Feb 21, 2023 | — |
| 424B5 | Prospectus supplement | Feb 16, 2023 | — |
| S-8 | Employee stock plan registration | Sep 30, 2022 | — |
| 424B5 | Prospectus supplement | Aug 1, 2022 | — |
| 424B5 | Prospectus supplement | Jul 28, 2022 | — |
| 424B5 | Prospectus supplement | May 20, 2022 | — |
| S-3/A | Form s-3/a | Nov 4, 2021 | — |
| S-3 | Shelf registration | Sep 24, 2021 | — |
| S-8 | Employee stock plan registration | Jul 23, 2021 | — |
| 424B5 | Prospectus supplement | Feb 11, 2021 | — |
| 424B5 | Prospectus supplement | Feb 9, 2021 | — |
| 424B5 | Prospectus supplement | Nov 12, 2020 | — |
| 424B5 | Prospectus supplement | May 21, 2020 | — |
| 424B5 | Prospectus supplement | May 19, 2020 | — |
| 424B3 | Prospectus | Feb 18, 2020 | — |
| S-8 | Employee stock plan registration | Feb 7, 2020 | — |
| S-3 | Shelf registration | Feb 7, 2020 | — |
| 424B3 | Prospectus | Jun 6, 2019 | — |
| 424B3 | Prospectus | May 3, 2019 | — |
| 424B3 | Prospectus | Feb 19, 2019 | — |
| 424B3 | Prospectus | Oct 15, 2018 | — |
| S-3 | Shelf registration | Oct 5, 2018 | — |
| S-8 | Employee stock plan registration | Sep 27, 2018 | — |
| S-3/A | Form s-3/a amended registration statement | Sep 26, 2018 | — |
| S-3 | Shelf registration | Sep 10, 2018 | — |
| 424B5 | Prospectus supplement | Mar 9, 2018 | — |
| 424B5 | Prospectus supplement | Mar 8, 2018 | — |
| S-8 | Employee stock plan registration | Oct 20, 2017 | — |
| 424B3 | Prospectus | Dec 13, 2016 | — |
| S-8 | Employee stock plan registration | Oct 14, 2016 | — |
| 424B5 | Prospectus supplement | Sep 30, 2016 | — |
| 424B5 | Prospectus supplement | Sep 29, 2016 | — |
| 424B3 | Prospectus | Sep 21, 2016 | — |
| 424B5 | Prospectus supplement | Mar 21, 2016 | — |
| 424B5 | Prospectus supplement | Mar 17, 2016 | — |
| S-8 | Employee stock plan registration | Dec 11, 2015 | — |
| S-3 | Shelf registration | Sep 4, 2015 | — |
| 424B3 | Prospectus | Jul 17, 2015 | — |
| POS AM | Post-effective amendment to form s-1 on form s-3 | Jun 12, 2015 | — |
| 424B4 | Prospectus | Feb 9, 2015 | — |
| S-1/A | Amended registration statement | Feb 4, 2015 | — |
| S-1/A | Amended registration statement | Jan 23, 2015 | — |
| S-1/A | Amended registration statement | Jan 8, 2015 | — |
| S-1/A | Amended registration statement | Jan 8, 2015 | — |
| S-1 | Registration statement | Nov 28, 2014 | — |
| 424B3 | Prospectus | Apr 28, 2014 | — |
| S-1 | Registration statement | Apr 11, 2014 | — |
Showing 73 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- VNRX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Henderson, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 93314
- Former names
- VOLITIONRX LTD (until Oct 27, 2026); STANDARD CAPITAL CORP (until Sep 29, 2011)
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.